Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Bilbe

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Receptor and Signal Transduction Research|November 23, 2006
Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disordersDaniel Hoyer, Deepak R Thakker, François Natt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand FliesDinesh Mondal, Caryn Bern, Debashis Ghosh, et al.
Neurobiology of Aging|December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complicationsBazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Plos Neglected Tropical Diseases|February 29, 2020
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasisSeth G Thacker, Ian L McWilliams, Beatrice Bonnet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2022
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas DiseaseFaustino Torrico, Joaquim Gascón, Lourdes Ortiz, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
Nature Reviews. Drug Discovery|September 2, 2021
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseasesFelix Calderón, Lluis Ballell, David Barros, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Seminars in Immunopathology|March 20, 2020
Implications of asymptomatic infection for the natural history of selected parasitic tropical diseasesJorge Alvar, Fabiana Alves, Bruno Bucheton, et al.
Clinical Microbiology Reviews|August 31, 2018
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and PerspectivesFabiana Alves, Graeme Bilbe, Séverine Blesson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Receptor and Signal Transduction Research|November 23, 2006
Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disordersDaniel Hoyer, Deepak R Thakker, François Natt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2018
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand FliesDinesh Mondal, Caryn Bern, Debashis Ghosh, et al.
Neurobiology of Aging|December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complicationsBazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Plos Neglected Tropical Diseases|February 29, 2020
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasisSeth G Thacker, Ian L McWilliams, Beatrice Bonnet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2022
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas DiseaseFaustino Torrico, Joaquim Gascón, Lourdes Ortiz, et al.
British Journal of Pharmacology|November 4, 2014
AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluationDominik Feuerbach, Nicole Pezous, Markus Weiss, et al.
Nature Reviews. Drug Discovery|September 2, 2021
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseasesFelix Calderón, Lluis Ballell, David Barros, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Seminars in Immunopathology|March 20, 2020
Implications of asymptomatic infection for the natural history of selected parasitic tropical diseasesJorge Alvar, Fabiana Alves, Bruno Bucheton, et al.
Clinical Microbiology Reviews|August 31, 2018
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and PerspectivesFabiana Alves, Graeme Bilbe, Séverine Blesson, et al.
Pageof 3